 |
|
|
| |
Efficacy and safety of MK-5172 and MK-8742 ± RIBAVIRIN IN Hcv Gt1 Infected Patients with cirrhosis or previous null reSPonse: FINAL RESULTS OF the C-WORTHY Study (PARTS A AND B)
|
| |
| |
Reported by Jules Levin
AASLD 2014 Boston Nov 7-11
Eric Lawitz, Edward J. Gane, Brian Pearlman, Edward Tam, Wayne Ghesquiere, Dominique Guyader, Laurent Alric, Jean-Pierre Bronowicki, Laura Lester, William Sievert, Reem H. Ghalib, Luis A. Balart, Fredrik Sund,
Martin Lagging, Frank Dutko, Anita Y. M. Howe,
Melissa Shaughnessy, Peggy Hwang, Janice Wahl,
Michael Robertson, Eliav Barr, Barbara Haber
|
| |
|
|
|
|
|
